Champions Oncology (CSBR) Operating Margin (2010 - 2026)
Champions Oncology (CSBR) posted Operating Margin of 3.77% for Q2 2026, down 126.37% on a QoQ basis from 1.67% in Q1 2026, and up 1247.0% year-over-year from 0.28% in Q2 2025.
Powered by 
Analysis
Champions Oncology (CSBR) Operating Margin (2010 - 2026) Analysis & Trends
Champions Oncology has reported Operating Margin for 17 years, with the latest figure at 3.77% in Q2 2026.
- On a quarterly basis, Operating Margin rose 1247.0% year-over-year to 3.77% in Q2 2026; TTM through Apr 2026 was 1.92%, a 991.0% decrease from a year earlier, with the FY2026 full-year figure at 1.92%, down 991.0% from the prior year.
- Operating Margin was 3.77% for Q2 2026 at Champions Oncology, down from 1.67% in the prior quarter.
- The five-year high for Operating Margin was 26.4% in Q1 2025, with the low at 21.44% in Q1 2024.
- Average Operating Margin over 5 years is 4.46%, with a median of 2.24% recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Operating Margin soared 4785 bps in 2025, then plunged 2807 bps in 2026.
- Over 5 years, Operating Margin stood at 0.05% in 2022, then slumped by 34564 bps to 16.89% in 2023, then soared by 132 bps to 5.43% in 2024, then tumbled by 77 bps to 1.23% in 2025, then sank by 407 bps to 3.77% in 2026.
- The last three Operating Margin figures came in at 3.77% (Q2 2026), 1.67% (Q1 2026), and 1.23% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 20.76% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 11.94% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 6.68% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -3.77% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -105.20% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3.77% |
| Jan 31, 2026 | -1.67% |
| Oct 31, 2025 | 1.23% |
| Jul 31, 2025 | -3.77% |
| Apr 30, 2025 | -16.24% |
| Jan 31, 2025 | 26.40% |
| Oct 31, 2024 | 5.43% |
| Jul 31, 2024 | 9.45% |
| Apr 30, 2024 | -1.94% |
| Jan 31, 2024 | -21.44% |
| Oct 31, 2023 | -16.89% |
| Jul 31, 2023 | -20.32% |
| Apr 30, 2023 | -19.29% |
| Jan 31, 2023 | -19.24% |
| Oct 31, 2022 | 0.05% |
| Jul 31, 2022 | -2.07% |
| Apr 30, 2022 | -2.42% |
| Jan 31, 2022 | 6.29% |
| Oct 31, 2021 | 2.23% |
| Jul 31, 2021 | -1.56% |